References:
1. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM,
et al. The 2016 revision to the World Health Organization classification
of myeloid neoplasms and acute leukemia. Blood. 2016 May
19;127(20):2391–405.
2. Nacheva EP, Grace CD, Brazma D, Gancheva K, Howard‐Reeves J, Rai L,
et al. Does BCR/ABL1 positive Acute Myeloid Leukaemia Exist? Br J
Haematol. 2013;161(4):541–50.
3. Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2018 update on
diagnosis, therapy and monitoring. Am J Hematol. 2018;93(3):442–59.
4. Neuendorff NR, Hemmati P, Arnold R, Ihlow J, Dörken B, Müller-Tidow
C, et al. BCR-ABL+ acute myeloid leukemia: are we always dealing with a
high-risk disease? Blood Adv. 2018 Jun 18;2(12):1409–11.
5. Pastoret C, Houot R. “Chronic myelogenous leukemia in primary blast
crisis” rather than “de novo BCR‐ABL1‐positive acute myeloid
leukemia.” Clin Case Rep. 2017 Apr 4;5(6):757–60.
6. Shao X, Chen D, Xu P, Peng M, Guan C, Xie P, et al. Primary
Philadelphia chromosome positive acute myeloid leukemia: A case report.
Medicine (Baltimore). 2018 Nov;97(44):e12949.
7. Reboursiere E, Chantepie S, Gac A-C, Reman O. Rare but authentic
Philadelphia-positive acute myeloblastic leukemia: Two case reports and
a literature review of characteristics, treatment and outcome. Hematol
Oncol Stem Cell Ther. 2015 Mar 1;8(1):28–33.
8. Ashar KM, Vaghasiya V, Patel SC. Megakaryocytic blast crisis in
chronic myeloid leukemia: A primary presentation. Indian J Pathol
Microbiol. 2017 Jul 1;60(3):445.